Biotechnology
Memgen Announces New Clinical Data on MEM-288 in Advanced/Metastatic NSCLC at ASCO 2023 Annual Meeting
06/06/2023 — TAMPA, Fla. — (BUSINESS WIRE) Memgen, Inc., a clinical-stage biotechnology company today announced updated clinical data from its first-in-human study of MEM-288, an oncolytic viral therapy, in patients […]
Airway Therapeutics Completes Enrollment in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
05/06/2023 — ATLANTA — (BUSINESS WIRE) Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory […]
Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
11/04/2023 — ATLANTA — (BUSINESS WIRE) Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory […]
Medidata Bolsters Senior Leadership Team to Further Accelerate the Digital Transformation of Life Sciences with Unmatched End-to-End Solutions
Pascal Daloz Named CEO and Michael Pray Named COO of Medidata 21/02/2023 — NEW YORK — (BUSINESS WIRE) Medidata, a Dassault Systèmes company, today announced a new leadership structure designed […]
Oxular Limited Announces Acceptance of IND for Suprachoroidal OXU-001 for the Treatment of Diabetic Macular Edema
OXU-001 represents potential best-in-class treatment for DME with just one, targeted administration per year Initiation of OXEYE Phase 2 clinical trial of OXU-001 in DME patients on-track for first quarter […]
CG Life and MC Services Form US-EU Strategic Partnership
Leading European and U.S. Life Science Communications Agencies Combine Forces to Deliver Integrated International Market Access 05/01/2023 — CHICAGO, DÜSSELDORF, MUNICH & SAN DIEGO — (BUSINESS WIRE) CG Life, an […]
Partnership to Fight Infectious Disease Launches European Chapter
Antimicrobial Resistance is Set to Become the Next Public Health Emergency 15/12/2022 — BRUSSELS — (BUSINESS WIRE) Infections due to antimicrobial resistance (AMR) are a significant threat to modern healthcare […]
Medidata Launches New myMedidata Native App to Expedite Study Start Up and Improve Patient Experience
Designed with customer and patient feedback to expand options for eCOA and other Decentralized Clinical Trial (DCT) activities 06/12/2022 — NEW YORK — (BUSINESS WIRE) Medidata, a Dassault Systèmes company, […]
Medimaps Group Appoints Meinhard F. Schmidt as Board Chairman; Adds Anne Le Grand and Five Additional Board Members
28/11/2022 — GENEVA — (BUSINESS WIRE) Medimaps Group (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for assessing bone health, today announced new appointments to its Board of […]
Alliance Healthcare and GIRP, the European Healthcare Distribution Association, Host Antimicrobial Resistance (AMR) Event
Inaugural event brings together leaders across the pharmaceutical and healthcare industries to facilitate collaboration, best-practice sharing and discussions on initiatives to address AMR 17/11/2022 — BRUSSELS — (BUSINESS WIRE) Alliance […]
Agendia Announces First Patient Enrolled in Prospective LESS Clinical Study, Sponsored by Unicancer, to De-escalate Endocrine Therapy in Women with Early Breast Cancer
The LESS study will evaluate reduced endocrine therapy for HR+/HER2- patients with MammaPrint® Ultra Low tumors to improve quality of life without compromising outcomes Study strengthens Agendia’s growing global footprint […]
Medidata Launches Rave Companion, the First Scalable Solution for Automating EHR Data Entry into Rave EDC
Rave Companion Modernizes the EDC User Experience, Saving Thousands of Potential Errors for Clinical Trial Sites and Data Managers Rave Companion increases data quality and can lower monitoring costs by […]
Seagen Names David R. Epstein as Chief Executive Officer and Director
-Roger Dansey, M.D., Appointed President, Research and Development – 10/11/2022 — BOTHELL, Wash. — (BUSINESS WIRE) Seagen Inc. (Nasdaq: SGEN) today announced that its Board of Directors has appointed David […]
Oxular Limited Appoints Industry Veteran James Jogerst as Chief Business Officer
07/11/2022 — OXFORD, England — (BUSINESS WIRE) Oxular Limited, a clinical-stage retinal therapeutics company developing long-lasting targeted treatments for retinal disorders to improve patients’ vision, today announced the appointment of […]
New Medidata Technology Helps Sponsors and CROs Improve Diversity and Inclusion in Clinical Trials
Intelligent Trials Diversity Module Addresses Critical Need to Increase Study Access and Engagement 13/10/2022 — NEW YORK — (BUSINESS WIRE) Medidata, a Dassault Systèmes company, has launched the Intelligent Trials […]
Nucleus Names MPO a Leader in 2022 Nucleus Control Tower Value Matrix
22/09/2022 — BOSTON — (BUSINESS WIRE) MPO today announced their recognition by Nucleus Research as a Leader in the 2022 Control Tower Value Matrix. We believe that in today’s highly […]
Caravan Biologix, Inc. Collaborates with MDimune on Cell-Derived NanoVesicles for Cancer
15/09/2022 — BRISTOL, N.J. & SEOUL — (BUSINESS WIRE) Caravan Biologix, Inc., a developer of novel cell-derived vesicle (CDV) therapeutics targeting specific cancers and gene therapy-related diseases, today announced that […]
CareDx Demonstrates Global Leadership at 29th International Congress of The Transplantation Society
Over 25 Abstracts Highlight Value of AlloSure and AlloSeq cfDNA 12/09/2022 — BRISBANE, Calif. — (BUSINESS WIRE) CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, […]
Eight Sleep Introduces Pod 3: The Latest Generation of Sleep Fitness Technology That Improves Sleep Quality by up to 32%
Maintaining the signature features of the Pod, the new generation features 10-times more computing power, twice the number of sensors with higher health tracking accuracy, and 5GHz Wi-Fi support. 27/07/2022 […]
Thermo Fisher Scientific Launches CE-IVD Marked TaqPath Respiratory Viral Select Panel
The PCR assay panel tests for five respiratory viruses in under three hours 11/07/2022 — CARLSBAD, Calif. — (BUSINESS WIRE) Thermo Fisher Scientific, the world leader in serving science, today […]
Agendia Presents Data from the FLEX Real World Evidence Trial in Seven Posters at ASCO 2022, Showcasing the Power of Its 30,000-Patient Breast Cancer Genome Project
Data show MammaPrint® is the first and most comprehensive FDA-cleared test for early breast cancer resulting in the ability to identify women who may be over- or under-treated if treatment […]
Agendia Presents Data at ASCO 2022 Pointing to New Signature ImPrint Immunotherapy Prediction and Expansion of Proprietary Genomic Tests’ Utility to Identify Patients Who Will Benefit Most from Specific Treatments
Data demonstrate Research Use Only ImPrint test’s ability to identify patients with high risk early breast cancer who may benefit from PD-1/PD-L1 checkpoint inhibition 04/06/2022 — IRVINE, Calif. & AMSTERDAM […]
LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with Peritoneal Metastasis at 2022 ASCO Annual Meeting
27/05/2022 — GUANGZHOU, China — (BUSINESS WIRE) LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that preliminary […]
Agendia Achieves Historic Milestone of Enrolling 10,000 Patients in FLEX, the Largest-Ever Prospective, Real-World-Evidence Trial for Patients With Early Stage Breast Cancer
Company to present multiple recent Registry sub-studies driving cancer care innovation at ASCO 2022 25/05/2022 — IRVINE, Calif. & AMSTERDAM — (BUSINESS WIRE) Agendia, Inc., a commercial-stage company focused on […]
Emendo Biotherapeutics’ next generation CRISPR gene editing technologies achieve breakthrough results with allele-specific approach for ELANE-related Severe Congenital Neutropenia as presented at ASGCT Annual Meeting
Emendo Biotherapeutics revealed pre-clinical data for the treatment of ELANE-related Severe Congenital Neutropenia using an allele-specific editing approach, generating a highly specific editing composition that achieves both no off-targets and […]
Celmatix Announces Achievement of Key Preclinical Milestones in Premature Menopause Prevention Drug Program
Lead AMHR2 agonist compound demonstrates high specific activity in biological assays and desired pharmacokinetic profile in preclinical animal studies 16/05/2022 — NEW YORK — (BUSINESS WIRE) Celmatix Inc. a biotechnology […]
Gnubiotics Announces Microbiome Innovation Strategic Partnership With ADM
09/05/2022 — LAUSANNE, Switzerland — (BUSINESS WIRE) Gnubiotics Sciences SA (Gnubiotics), announced today a strategic partnership agreement with ADM, a global leader in human and animal nutrition. The strategic partnership […]
Medicago Announces Publication of Phase 3 COVID-19 Vaccine Study Results in New England Journal of Medicine
Study results were included in the submission to Health Canada leading to Notice of Compliance 05/05/2022 — QUEBEC CITY — (BUSINESS WIRE) Medicago today announced the publication of the results […]
Agendia Demonstrates Accessibility and Affordability of MammaPrint® and BluePrint® in Europe at ESMO Breast Cancer 2022
Next-generation sequencing version of MammaPrint and BluePrint enables decentralized testing in CE-mark jurisdictions like Germany Analysis for Belgian Health Care Package shows MammaPrint yields cost-savings for breast cancer care systemically […]
Evaxion to Utilize Personalis’ ImmunoID NeXT Platform® to Evaluate Efficacy of Combination Therapy for Late-Stage Melanoma
26/04/2022 — MENLO PARK, Calif. & COPENHAGEN, Denmark — (BUSINESS WIRE) Evaxion Biotech A/S (Nasdaq: EVAX) and Personalis (Nasdaq: PSNL) announced today that Evaxion will deploy Personalis’ ImmunoID NeXT Platform […]